lymphopenia
Showing 1 - 25 of 2,499
or Prognostic Risk Factor for Disease Severity in Elderly
Completed
- Lymphopenia
- +2 more
- observation no intervention
-
Brussel, BelgiumUZ brussel
Jan 30, 2023
Idiopathic CD4 Lymphopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Recombinant human
Not yet recruiting
- Idiopathic CD4 Lymphopenia
- Recombinant human interleukin (IL) 7-hyFc
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Stroke-induced Immunodepression in Neurorehabilitation
Completed
- Stroke
- +2 more
- Neurorehabilitation
-
Pavia, ItalyHeadache Science & Neurorehabilitation Center
Jun 1, 2023
Progressive Multifocal Leukoencephalopathy Trial run by the NINDS (NT-I7)
Recruiting
- Progressive Multifocal Leukoencephalopathy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 2, 2022
Adenosine Deaminase Enzyme Deficiency in Lymphopenia and/or
Enrolling by invitation
- Adenosine Deaminase Deficiency
- ADENOSINE DEAMINASE TEST
-
Konya, Meram, TurkeyKonya Necmettin Erbakan University
Mar 18, 2022
CD8+ T-cell PET/CT Imaging in COVID-19 Patients
Recruiting
- Lymphopenia Due to COVID-19
- +2 more
- [89Zr]Df-IAB22M2C PET/CT scan
-
Nijmegen, Gelderland, NetherlandsRadboud university medical center
Jun 2, 2022
Covid19, Lymphopenia Trial in Shenyang (nicotinamide)
Completed
- Covid19
- Lymphopenia
-
Shenyang, Liaoning, ChinaGeneral Hospital of Northern Theater Command
Oct 29, 2021
Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous
Active, not recruiting
- Malignant Neoplasms of Brain
- tetanus toxoid
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Natural History of Idiopathic CD4+ Lymphocytopenia
Recruiting
- Idiopathic CD4+ Lymphocytopenia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Idiopathic CD4 T Cell Lymphocytopenia Trial run by the NIAID (Gardasil 9)
Recruiting
- Idiopathic CD4 T Cell Lymphocytopenia
- Gardasil 9
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 10, 2023
Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
- Idiopathic CD4-Positive
- T-Lymphocytopenia
- Filgrastim
- Plerixafor
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Enzyme Deficiency in Pulmonology Clinics (ADA)
Active, not recruiting
- Bronchiectasis
- +2 more
- adenosine deaminase enzyme deficiency test
-
Ankara, Mamak, TurkeyAnkara University Medical Faculty
Mar 18, 2022
Solid Tumor Malignancies Trial in Houston (Autologous lymphocyte infusion (ALI))
Recruiting
- Solid Tumor Malignancies
- Autologous lymphocyte infusion (ALI)
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Lymphocyte Reconstitution After Lymphopenia in Participants
Completed
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Dimethyl fumarate
-
Amiens, France
- +31 more
Oct 18, 2021
Malignant Tumors Brain Trial in Durham (RNA-loaded dendritic cell vaccine, basiliximab)
Completed
- Malignant Neoplasms Brain
- RNA-loaded dendritic cell vaccine
- basiliximab
-
Durham, North CarolinaDuke University Medical Center
Mar 8, 2021
Breast Cancer, Cancer, Therapy-Related, Chemo Effect Trial in Xi'an (Transcutaneous vagus nerve stimulation)
Recruiting
- Breast Cancer
- +3 more
- Transcutaneous vagus nerve stimulation
-
Xi'an, Shaanxi, ChinaXidian University
Sep 27, 2021
Corona Virus Infection Trial in Madrid (T memory cells and NK cells)
Recruiting
- Corona Virus Infection
- T memory cells and NK cells
-
Madrid, SpainHospital Universitario La Paz
Oct 14, 2020
Human Immunodeficiency Virus (HIV) Testing
Completed
- HIV Seropositivity
- CD4+ T Lymphocytopenia
- Medical record review
-
Jena, Thuringia, GermanyUniversity Hospital Jena
Aug 30, 2021
COVID-19, Lymphocytopenia Trial in Brazil (Interleukin-7, PLACEBO)
Terminated
- COVID-19
- Lymphocytopenia
- Interleukin-7
- PLACEBO
-
Porto Alegre, RIO Grande DO SUL, Brazil
- +5 more
Mar 30, 2022
Postoperative Lymphopenia as Risk Factor for Postoperative
Completed
- Cancer of the Digestive System
- Thoracic Diseases
- Collection of plasma cell rate
-
Angers, France
- +19 more
Jan 15, 2021
COVID-19, Lymphocytopenia Trial in United Kingdom (Interleukin-7, Placebos)
Terminated
- COVID-19
- Lymphocytopenia
- Interleukin-7
- Placebos
-
Birmingham, United Kingdom
- +12 more
Mar 30, 2022
Glioblastoma, Gliosarcoma Trial in Durham (EGFRvIII CAR T cells)
Terminated
- Glioblastoma
- Gliosarcoma
- EGFRvIII CAR T cells
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke
Jul 8, 2020
HIV-1-infection, CD4+ T Lymphocytopenia, Immune Deficiency Trial in Ciudad de México (Pyridostigmine Bromide, Placebo)
Suspended
- HIV-1-infection
- +3 more
- Pyridostigmine Bromide
- Placebo
-
Ciudad de México, Tlalpan, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Apr 8, 2020
Investigation of ADA Enzyme Deficiency
Enrolling by invitation
- Adenosine Deaminase Deficiency
- adenosine deaminase test
-
Ankara, Mamak, TurkeyAnkara Üniversitesi Tıp Fakültesi
Mar 18, 2022
Lung Cancer Trial in Nashville (Evidence-based radiation dose limitation to the vertebral bone marrow)
Not yet recruiting
- Lung Cancer
- Evidence-based radiation dose limitation to the vertebral bone marrow
-
Nashville, TennesseeVanderbilt-Ingram Service for Timely Access
Jul 1, 2022